HK1203157A1 - Sustained delivery of molecules using peptide surfactants and uses thereof - Google Patents
Sustained delivery of molecules using peptide surfactants and uses thereofInfo
- Publication number
- HK1203157A1 HK1203157A1 HK15103754.3A HK15103754A HK1203157A1 HK 1203157 A1 HK1203157 A1 HK 1203157A1 HK 15103754 A HK15103754 A HK 15103754A HK 1203157 A1 HK1203157 A1 HK 1203157A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- molecules
- sustained delivery
- peptide surfactants
- surfactants
- peptide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1273—Polymersomes; Liposomes with polymerisable or polymerised bilayer-forming substances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261653782P | 2012-05-31 | 2012-05-31 | |
PCT/US2013/043572 WO2013181511A1 (en) | 2012-05-31 | 2013-05-31 | Sustained delivery of molecules using peptide surfactants and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1203157A1 true HK1203157A1 (en) | 2015-10-23 |
Family
ID=49673920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15103754.3A HK1203157A1 (en) | 2012-05-31 | 2015-04-17 | Sustained delivery of molecules using peptide surfactants and uses thereof |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150147384A1 (ja) |
EP (1) | EP2854778A4 (ja) |
JP (2) | JP2015519374A (ja) |
CA (1) | CA2874003A1 (ja) |
HK (1) | HK1203157A1 (ja) |
SG (1) | SG11201407696WA (ja) |
WO (1) | WO2013181511A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014152751A1 (en) | 2013-03-14 | 2014-09-25 | Massachusetts Institute Of Technology | Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies |
CN106832000B (zh) * | 2017-01-17 | 2021-06-22 | 国家纳米科学中心 | 一种可在肿瘤细胞溶酶体内发生形貌转换的多肽脂质体 |
US11311568B2 (en) * | 2017-11-09 | 2022-04-26 | Purmx Therapeutics, Inc. | Therapeutic pharmaceutical composition for cancer including miRNA |
US11324703B2 (en) | 2017-12-15 | 2022-05-10 | 3-D Matrix, Ltd. | Surfactant peptide nanostructures and uses thereof in drug delivery |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7179784B2 (en) * | 2001-07-10 | 2007-02-20 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
JP3959453B2 (ja) * | 2002-03-14 | 2007-08-15 | 沖電気工業株式会社 | 翻訳仲介システム及び翻訳仲介サーバ |
US8187621B2 (en) * | 2005-04-19 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Methods and compositions for treating post-myocardial infarction damage |
WO2008136820A1 (en) * | 2007-05-01 | 2008-11-13 | Massachusetts Institute Of Technology | Stabilization of mammalian membrane proteins by short surfactant peptides |
US20090069547A1 (en) * | 2007-05-01 | 2009-03-12 | Massachusetts Institute Of Technology | Stabilization of mammalian membrane proteins by short surfactant peptides |
WO2009018467A2 (en) * | 2007-07-31 | 2009-02-05 | Massachusetts Institute Of Technology | Bio-sensing nanodevice |
WO2010014903A1 (en) * | 2008-07-31 | 2010-02-04 | Massachusetts Institute Of Technology | Multiplexed olfactory receptor-based microsurface plasmon polariton detector |
KR101647521B1 (ko) * | 2008-08-27 | 2016-08-10 | 가부시끼가이샤 쓰리디 매트릭스 | 트랜스펙션제 |
JP2010222338A (ja) * | 2009-02-27 | 2010-10-07 | Three D Matrix:Kk | 核酸移送担体 |
JP2011012042A (ja) * | 2009-07-03 | 2011-01-20 | Three D Matrix:Kk | 核酸徐放担体 |
JP2011126855A (ja) * | 2009-12-15 | 2011-06-30 | Three D Matrix:Kk | タンパク質の凝集抑制剤 |
-
2013
- 2013-05-31 WO PCT/US2013/043572 patent/WO2013181511A1/en active Application Filing
- 2013-05-31 JP JP2015515229A patent/JP2015519374A/ja active Pending
- 2013-05-31 CA CA2874003A patent/CA2874003A1/en not_active Abandoned
- 2013-05-31 EP EP13797704.7A patent/EP2854778A4/en not_active Withdrawn
- 2013-05-31 SG SG11201407696WA patent/SG11201407696WA/en unknown
-
2014
- 2014-11-18 US US14/546,454 patent/US20150147384A1/en not_active Abandoned
-
2015
- 2015-04-17 HK HK15103754.3A patent/HK1203157A1/xx unknown
-
2017
- 2017-10-02 JP JP2017192847A patent/JP2018052935A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2013181511A1 (en) | 2013-12-05 |
EP2854778A4 (en) | 2016-03-30 |
JP2018052935A (ja) | 2018-04-05 |
EP2854778A1 (en) | 2015-04-08 |
US20150147384A1 (en) | 2015-05-28 |
CA2874003A1 (en) | 2013-12-05 |
SG11201407696WA (en) | 2014-12-30 |
JP2015519374A (ja) | 2015-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL260045B (en) | Polypeptide structures and their uses | |
EP2870170A4 (en) | NOVEL PEPTIDES AND THEIR USE | |
HK1197184A1 (en) | Selective delivery molecules and methods of use | |
EP2788370A4 (en) | MODIFIED MINI-HEPCIDINE PEPTIDES AND METHODS OF USE | |
EP2721061A4 (en) | STABILIZED VARIANT MAML PEPTIDES AND USES THEREOF | |
IL279676A (en) | Recombinant proteins and therapeutic uses | |
EP2782589A4 (en) | ANTIMICROBIAL PEPTIDES AND METHOD FOR THEIR USE | |
HK1201454A1 (en) | Therapeutic agents and uses thereof | |
SG11201500111VA (en) | Peptides and uses thereof | |
EP2738255A4 (en) | PEPTIDE FROM ERAP1 AND ITS USE | |
HK1204772A1 (en) | Aromatic-cationic peptides and uses of same | |
HK1203161A1 (en) | Peptides and methods of using same | |
SG11201501646PA (en) | Peptides and their uses | |
ZA201401210B (en) | Peptide nanoparticles and uses thereof | |
EP2793921A4 (en) | PEPTIDES DERIVED FROM SAPOSIN A AND USES THEREOF | |
PL2667880T3 (pl) | Oligopeptydy metaloproteinaz i ich zastosowanie terapeutyczne | |
HK1203157A1 (en) | Sustained delivery of molecules using peptide surfactants and uses thereof | |
EP2825548A4 (en) | MODIFIED KISSPEPTIN PEPTIDES AND USES THEREOF | |
EP2740740A4 (en) | PEPTIDE DERIVED FROM A LIGAND EDAR AND USES THEREOF | |
EP2907870A4 (en) | REPROGRAMMING PEPTIDE AND USE THEREOF | |
EP2762149A4 (en) | PEPTIDE DERIVED FROM ERYTHROPOIETIN AND USE THEREOF | |
HK1206977A1 (en) | Aromatic-cationic peptides and uses of same | |
EP2918600A4 (en) | NEW PEPTIDE AND ITS USE | |
EP2873676A4 (en) | PEPTIDE WITH LOW MOLECULAR WEIGHT AND USE THEREOF |